Biomarin Pharmaceutical Income Statement (2009-2025) | BMRN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2009	Jun2009	Sep2009	Dec2009	Mar2010	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Sep2015	Dec2015	Dec2016	Jun2017	Dec2017	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.07B	0.08B	0.08B	0.09B	0.08B	0.09B	0.10B	0.10B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.13B	0.13B	0.13B	0.14B	0.14B	0.15B	0.15B	0.19B	0.18B	0.23B	0.21B	0.23B		0.32B		0.37B	0.39B	0.35B	0.40B	0.39B	0.46B	0.45B	0.50B	0.43B	0.48B	0.45B	0.49B	0.50B	0.41B	0.45B	0.52B	0.53B	0.51B	0.54B	0.60B	0.60B	0.58B	0.65B	0.65B	0.71B	0.75B	0.75B	0.75B	0.83B	0.78B
Cost of Revenue	0.00B	0.02B	0.01B	0.02B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.02B	0.02B	0.03B	0.02B	0.02B	0.03B	0.03B	0.04B	0.04B	0.04B		0.06B		0.08B	0.08B	0.08B	0.09B	0.08B	0.10B	0.10B	0.11B	0.10B	0.19B	0.13B	0.12B	0.13B	0.10B	0.12B	0.12B	0.12B	0.12B	0.15B	0.14B	0.13B	0.13B	0.14B	0.13B	0.13B	0.19B	0.14B	0.15B	0.15B	0.14B
Gross Profit	0.07B	0.06B	0.07B	0.07B	0.07B	0.08B	0.08B	0.08B	0.09B	0.09B	0.09B	0.09B	0.10B	0.10B	0.10B	0.11B	0.11B	0.11B	0.11B	0.13B	0.13B	0.16B	0.15B	0.19B	0.17B	0.19B		0.26B		0.29B	0.31B	0.28B	0.31B	0.31B	0.36B	0.36B	0.39B	0.33B	0.29B	0.33B	0.37B	0.37B	0.31B	0.33B	0.40B	0.41B	0.39B	0.39B	0.46B	0.46B	0.45B	0.51B	0.52B	0.58B	0.56B	0.61B	0.59B	0.68B	0.64B
Operating items
Amortization - Intangibles		0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	-0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.01B	0.00B	-0.04B		0.01B		0.01B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B
Research & Development	34.36B	0.03B	0.03B	0.03B	0.03B	0.04B	0.04B	0.04B	0.05B	0.05B	0.06B	0.06B	0.07B	0.08B	0.07B	0.08B	0.08B	0.09B	0.09B	0.10B	0.09B	0.11B	0.13B	0.14B	0.16B	0.18B		0.14B		0.18B	0.16B	0.18B	0.18B	0.19B	0.17B	0.17B	0.14B	0.18B	0.15B	0.16B	0.15B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B	0.17B	0.17B	0.18B	0.19B	0.21B	0.20B	0.18B	0.18B	0.17B	0.16B	0.16B	0.41B
Selling, General & Administrative	28.57B	0.03B	0.03B	0.04B	0.03B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.05B	0.05B	0.05B	0.05B	0.06B	0.05B	0.05B	0.06B	0.07B	0.06B	0.07B	0.07B	0.10B	0.09B	0.11B		0.14B		0.15B	0.15B	0.16B	0.16B	0.16B	0.17B	0.19B	0.19B	0.18B	0.18B	0.20B	0.17B	0.18B	0.18B	0.22B	0.19B	0.20B	0.22B	0.21B	0.21B	0.21B	0.22B	0.26B	0.23B	0.26B	0.25B	0.27B	0.21B	0.23B	0.27B
Other Operating Expenses		0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.00B	-0.00B	0.00B	0.02B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.07B		-0.00B	0.38B		0.00B		0.02B	0.00B	0.03B	0.00B	0.01B	0.00B	0.01B	0.06B	0.00B	0.00B	-0.01B	-0.00B	0.00B	0.01B	0.00B	0.11B	-0.00B	0.00B		-0.01B	-0.00B	-0.00B	-0.02B	0.01B	-0.00B	0.01B		-0.00B	0.00B	0.01B
Operating Expenses	62.93B	0.08B	0.07B	0.08B	0.08B	0.09B	0.10B	0.10B	0.11B	0.11B	0.13B	0.13B	0.14B	0.15B	0.14B	0.18B	0.16B	0.16B	0.19B	0.20B	0.18B	0.21B	0.17B	0.29B	0.29B	0.13B		0.36B		0.40B	0.41B	0.39B	0.45B	0.43B	0.46B	0.46B	0.40B	0.47B	0.53B	0.50B	0.46B	0.49B	0.46B	0.52B	0.38B	0.49B	0.51B	0.55B	0.53B	0.53B	0.55B	0.62B	0.56B	0.59B	0.63B	0.59B	0.52B	0.55B	0.82B
Operating Income	-62.85B	0.00B	0.01B	0.01B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.02B	-0.02B	-0.02B	-0.03B	-0.01B	-0.05B	-0.03B	-0.02B	-0.05B	-0.05B	-0.03B	-0.02B	0.01B	-0.06B	-0.08B	0.10B		-0.04B		-0.03B	-0.02B	-0.04B	-0.05B	-0.04B	0.00B	-0.01B	0.10B	-0.04B	-0.06B	-0.05B	0.03B	0.01B	-0.05B	-0.07B	0.14B	0.04B	-0.00B	-0.01B	0.06B	0.07B	0.03B	0.03B	0.09B	0.12B	0.11B	0.16B	0.22B	0.28B	-0.05B
EBIT	-62.85B	0.00B	0.01B	0.01B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.02B	-0.02B	-0.02B	-0.03B	-0.01B	-0.05B	-0.03B	-0.02B	-0.05B	-0.05B	-0.03B	-0.02B	0.01B	-0.06B	-0.08B	0.10B		-0.04B		-0.03B	-0.02B	-0.04B	-0.05B	-0.04B	0.00B	-0.01B	0.10B	-0.04B	-0.06B	-0.05B	0.03B	0.01B	-0.05B	-0.07B	0.14B	0.04B	-0.00B	-0.01B	0.06B	0.07B	0.03B	0.03B	0.09B	0.12B	0.11B	0.16B	0.22B	0.28B	-0.05B
Non-operating items
Interest & Investment Income		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B		0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
Net income details
EBT	-62.85B	0.00B	0.01B	0.01B	0.00B	0.00B	-0.00B	-0.05B	0.00B	-0.00B	-0.02B	-0.09B	-0.02B	-0.03B	-0.01B	-0.10B	-0.04B	-0.02B	-0.05B	-0.06B	-0.03B	-0.03B	0.00B	-0.07B	-0.09B	0.09B		-0.05B		-0.03B	-0.02B	-0.04B	-0.05B	-0.04B	0.01B	-0.01B	0.10B	-0.04B	-0.06B	-0.05B	0.02B	0.01B	-0.05B	-0.07B	0.13B	0.03B	-0.00B	-0.02B	0.06B	0.07B	0.04B	0.02B	0.11B	0.13B	0.13B	0.17B	0.24B	0.30B	-0.03B
Tax Provisions		0.00B	0.00B	-0.00B	0.00B	0.00B	-0.22B	-0.01B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.01B	0.01B	-0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	-0.00B	0.03B	0.00B	0.10B		-0.01B		-0.01B	-0.01B	-0.04B	0.00B	-0.00B	-0.05B	-0.02B	0.02B	-0.01B	-0.85B	-0.06B	0.01B	0.00B	-0.01B	-0.01B	0.01B	0.01B	0.00B	-0.02B	0.01B	0.01B	0.00B	-0.00B	0.02B	0.02B	0.03B	0.04B	0.05B	0.06B	0.00B
Profit After Tax	0.01B	0.00B	0.01B	0.00B	0.00B	-0.00B	0.22B	-0.01B	-0.00B	-0.01B	-0.02B	-0.03B	-0.02B	-0.03B	-0.01B	-0.05B	-0.04B	-0.02B	-0.05B	-0.06B	-0.04B	-0.03B	0.01B	-0.07B	-0.09B	0.07B		-0.04B		-0.02B	-0.01B	-0.00B	-0.06B	-0.04B	0.06B	0.02B	0.08B	-0.03B	0.78B	0.02B	0.02B	0.01B	-0.04B	-0.06B	0.12B	0.03B	-0.01B	-0.00B	0.05B	0.06B	0.04B	0.02B	0.09B	0.11B	0.11B	0.12B	0.19B	0.24B	-0.03B
Equity Income		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B		-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B
Income from Continuing Operations	-62.85B	0.00B	0.01B	0.01B	0.00B	-0.00B	0.22B	-0.04B	-0.00B	-0.01B	-0.02B	-0.09B	-0.02B	-0.03B	-0.01B	-0.11B	-0.04B	-0.02B	-0.05B	-0.07B	-0.04B	-0.03B	0.01B	-0.10B	-0.09B	-0.01B		-0.04B		-0.02B	-0.01B	-0.00B	-0.06B	-0.04B	0.06B	0.02B	0.08B	-0.03B	0.78B	0.02B	0.02B	0.01B	-0.04B	-0.06B	0.12B	0.03B	-0.01B	-0.00B	0.05B	0.06B	0.04B	0.02B	0.09B	0.11B	0.11B	0.12B	0.19B	0.24B	-0.03B
Consolidated Net Income	-62.85B	0.00B	0.01B	0.01B	0.00B	-0.00B	0.22B	-0.04B	-0.00B	-0.01B	-0.02B	-0.09B	-0.02B	-0.03B	-0.01B	-0.11B	-0.04B	-0.02B	-0.05B	-0.07B	-0.04B	-0.03B	0.01B	-0.10B	-0.09B	-0.01B		-0.04B		-0.02B	-0.01B	-0.00B	-0.06B	-0.04B	0.06B	0.02B	0.08B	-0.03B	0.78B	0.02B	0.02B	0.01B	-0.04B	-0.06B	0.12B	0.03B	-0.01B	-0.00B	0.05B	0.06B	0.04B	0.02B	0.09B	0.11B	0.11B	0.12B	0.19B	0.24B	-0.03B
Income towards Parent Company	-62.85B	0.00B	0.01B	0.01B	0.00B	-0.00B	0.22B	-0.04B	-0.00B	-0.01B	-0.02B	-0.09B	-0.02B	-0.03B	-0.01B	-0.11B	-0.04B	-0.02B	-0.05B	-0.07B	-0.04B	-0.03B	0.01B	-0.10B	-0.09B	-0.01B		-0.04B		-0.02B	-0.01B	-0.00B	-0.06B	-0.04B	0.06B	0.02B	0.08B	-0.03B	0.78B	0.02B	0.02B	0.01B	-0.04B	-0.06B	0.12B	0.03B	-0.01B	-0.00B	0.05B	0.06B	0.04B	0.02B	0.09B	0.11B	0.11B	0.12B	0.19B	0.24B	-0.03B
Net Income towards Common Stockholders	-62.85B	0.00B	0.01B	0.01B	0.00B	-0.00B	0.22B	-0.04B	-0.00B	-0.01B	-0.02B	-0.09B	-0.02B	-0.03B	-0.01B	-0.11B	-0.04B	-0.02B	-0.05B	-0.07B	-0.04B	-0.03B	0.01B	-0.10B	-0.09B	-0.01B		-0.04B		-0.02B	-0.01B	-0.00B	-0.06B	-0.04B	0.06B	0.02B	0.08B	-0.03B	0.78B	0.02B	0.02B	0.01B	-0.04B	-0.06B	0.12B	0.03B	-0.01B	-0.00B	0.05B	0.06B	0.04B	0.02B	0.09B	0.11B	0.11B	0.12B	0.19B	0.24B	-0.03B
Additional items
EPS (Basic)	-0.00B	0.01	0.07	0.09	0.01	0.00	2.13	-0.40	-0.04	-0.05	-0.16	-0.81	-0.21	-0.27	-0.04	-0.90	-0.31	-0.15	-0.38	-0.51	-0.26	-0.23	0.05	-0.65	-0.57	-0.05		-0.21		-0.09	-0.07	-0.02	-0.32	-0.21	0.31	0.09	0.45	-0.16	4.33	0.09	0.10	0.07	-0.20	-0.32	0.66	0.15	-0.04	-0.01	0.27	0.30	0.21	0.11	0.47	0.56	0.56	0.66	0.97	1.25	-0.16
EPS (Weighted Average and Diluted)		0.01	0.07	0.09	0.01	-0.01	1.68	-0.33	-0.04	-0.05	-0.16	-0.24		-0.27			-0.31	-0.16	-0.38		-0.27	-0.23	0.05	-0.48	-0.60	0.44					-0.07	-0.02	-0.32	-0.21	0.30	0.09	0.44	-0.16	4.01	0.11	0.09	0.07	-0.20	-0.32	0.63	0.15	-0.04	0.00	0.27	0.29	0.21	0.10	0.46	0.55	0.55	0.64	0.95	1.23	-0.16
Shares Outstanding (Weighted Average)	0.00B	0.00B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.12B	0.12B	0.13B		0.14B	0.14B				0.15B		0.16B	0.17B	0.17B	0.17B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.18B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B
Shares Outstanding (Diluted Average)		0.10B	0.00B	0.10B	0.10B	0.10B	0.13B	0.13B	0.11B																		0.17B		0.17B		0.18B	0.18B	0.18B	0.18B	0.19B	0.18B	0.19B	0.18B	0.20B	0.19B	0.18B	0.19B	0.18B	0.18B	0.19B	0.19B	0.19B	0.19B	0.19B	0.19B	0.20B	0.19B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B
EBITDA	-62.85B	0.00B	0.01B	0.01B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.01B	-0.01B	-0.02B	-0.03B	-0.03B	-0.01B	-0.05B	-0.04B	-0.02B	-0.04B	-0.05B	-0.04B	-0.03B	0.02B	-0.06B	-0.10B	0.10B		-0.06B		0.01B	-0.01B	-0.04B	-0.04B	-0.04B	0.07B	-0.01B	0.10B	-0.03B	0.77B	-0.05B	0.04B	0.01B	-0.03B	-0.07B	0.11B	0.05B	0.01B	-0.01B	0.04B	0.05B	0.07B	0.03B	0.12B	0.14B	0.08B	0.16B	0.14B	0.18B	-0.02B
Interest Expenses		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B		0.01B		0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Tax Rate		28.46%	12.46%	-9.75%	35.59%	182.38%	4,806.24%	14.72%	1,212.21%	-332.82%	10.53%	-4.17%	0.14%	1.27%	54.45%	-13.44%	10.58%	-6.12%	-1.35%	-19.40%	-10.08%	-20.82%	-131.14%	-45.15%	-0.53%	108.83%		19.13%		42.45%	34.99%	91.57%	-6.64%	10.65%	-460.33%	253.60%	19.70%	30.97%	1,382.02%	136.34%	25.22%	8.58%	20.94%	13.03%	9.98%	20.62%	-249.37%	98.58%	10.40%	20.86%	3.10%	-5.42%	16.00%	18.89%	21.10%	26.35%	22.01%	19.25%	-16.79%

Research Tools

Biomarin Pharmaceutical Income Statement (2009-2025) | BMRN

Create an account

Sign In

Reset Password